Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Rapid Micro Biosystems FY2025 Revenue expected to be more than $32.00M vs $32.60M Est

Author: Benzinga Newsdesk | August 12, 2025 06:33am
Rapid Micro Biosystems (NASDAQ:RPID) FY2025 Revenue expected to be more than $32.00M vs $32.60M Est

Posted In: RPID

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist